Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x100px

Persons > All

Find below all kinds of persons.

Total search results: 8918 | Ordered by Country (ascending)
next pagenext page 1 2 3 ... 73 74 75 ... 88 89 90  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
Foster, Jason C. (Oribiotech 202001– CEO) Chief Executive Officer (CEO) Ori Biotech (Oribiotech) (Group) United Kingdom (GB)
Foulger, Paul (EKF Diagnostics 201307– Interim Finance Director before Company Secretary) Chief Financial Officer (CFO) EKF Diagnostics (Group) United Kingdom (GB)
Fowles, Richard (United Kingdom (govt) 201010 Category Manager at RCUK SSC Ltd) n. a. United Kingdom (GB) (govt) United Kingdom (GB)
Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) Professor University of London United Kingdom (GB)
Friedrich, Eva (SDL 201604 Field Marketing Manager DACH) n. a. SDL (Group) United Kingdom (GB)
Friedrich, Glenn A. (Kymab 201511 COO) Chief Operating Officer (COO) Sanofi (Group) [since May 2011] United Kingdom (GB)
Fulton, Gemma (BioOutsource 201406 Sales + Marketing Associate) Sales Manager / Marketing Manager Sartorius (Group) United Kingdom (GB)
Gadsby, Martin (Optimal Industrial 202204 CEO + Co-Founder) Chief Executive Officer (CEO) Bruker (Group) United Kingdom (GB)
Galbraith, Daniel (BioOutsource 201402 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Sartorius (Group) United Kingdom (GB)
Galbraith, Susan (AstraZeneca 201212 VP + Head Oncology Innovative Medicines Unit) President/Director/Head Business Group/Unit/Division AstraZeneca (Group) United Kingdom (GB)
Gales, Ann (A Gales Consulting 201709 Managing Partner) Managing Partner A Gales Consulting Ltd. United Kingdom (GB)
Gallagher, Stephen (Steve) (Dotmatics 200612 CEO) Chief Executive Officer (CEO) Insightful Science (Group) United Kingdom (GB)
Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) Public Relations Manager / Investor Relations Manager ICR (Group) United Kingdom (GB)
Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) Chief Executive Officer (CEO) GSK (Group) United Kingdom (GB)
George, Peter (Clinigen Group 201303 CEO) Chief Executive Officer (CEO) Clinigen (Group) United Kingdom (GB)
Gibson-Brade, Emma (Peak Scientific 201304– Market Researcher) market research Peak Scientific (Group) United Kingdom (GB)
Gilham, Ian D. (Axis-Shield 200801 CEO– before COO) Chief Executive Officer (CEO) Abbott (Group) United Kingdom (GB)
Gladsden, Brian (Mosaic Therapeutics 202304– CEO before Novartis + Bayer) Chief Executive Officer (CEO) Mosaic Therapeutics Ltd. United Kingdom (GB)
Glass, Steve (BioMarin Europe 200801– VP + General Manager before Altana) Managing Director BioMarin (Group) United Kingdom (GB)
Goldman, Jonathan (Abzena 202201 CEO formerly Aptuit CEO) Chief Executive Officer (CEO) Abzena (Group) United Kingdom (GB)
Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder) Chief Executive Officer (CEO) Compass Pathways (Group) United Kingdom (GB)
Gooch, Daniel (Scius Communciations 202109 formerly Instinctif Partners 201509) Public Relations Manager / Investor Relations Manager Scius Communications (GB) United Kingdom (GB)
Grabulovski, Dragan (Bellevue 202109– Venture Partner at Pureos Bioventures before Covagen CSO + co-founder) Partner (venture partner) Bellevue (Group) United Kingdom (GB)
Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics) General Partner (venture partner) Medicxi Ventures (formerly Index Ventures Life Sciences) United Kingdom (GB)
Green, Nicholas (Coulter Partners 201711 Managing Partner) Managing Partner Coulter Partners (The Coulter Partnership Ltd.) United Kingdom (GB)
Green, Nicola (Halesway Ltd 201201– Account Director before Alto Marketing 201110 Account Director, Life Science) public relations / investor relations Halesway Ltd. United Kingdom (GB)
Griffin, Conor (Hume Brophy 201802 Managing Director International Healthcare) Managing Director Hume Brophy Communications United Kingdom (GB)
Griffiths, David (LGC 201704 Managing Director of LGC LMS division) Managing Director LGC (Group) United Kingdom (GB)
Günther, Rolf H. (Bicycle Therapeutics 201204– CEO before Affimed 2004– CEO + COO before Aventis Behring) Chief Executive Officer (CEO) Bicycle Therapeutics (Group) United Kingdom (GB)
Haas, Eva (Optimum Strategic Communications 201710– before Hume Brophy) Public Relations Manager / Investor Relations Manager Optimum Strategic Communications United Kingdom (GB)
Haigh, Robert (Macomics 202007– CEO + Executive Chair of Ikarovec before Ferring + Boehringer Ingelheim) Chief Executive Officer (CEO) Macomics Ltd. United Kingdom (GB)
Hall, Bridget (Fujifilm 201310 Communications Manager at Fujifilm Diosynth Biotechnologies UK Ltd) Public Relations Manager / Investor Relations Manager Fujifilm (Group) United Kingdom (GB)
Hall, Matthew (Oncimmune 201906 CFO + 201904– Managing Director at Oncimmune Germany GmbH) Chief Financial Officer (CFO) Freenome (Group) United Kingdom (GB)
Hallett, David (Exscientia 202001–COO before Evotec + Merck & Co) Chief Operating Officer (COO) Exscientia (Group) United Kingdom (GB)
Hamacher, Christiane (Biocon 201910 CEO of Biocon Biologics) Chief Executive Officer (CEO) Biocon (Group) United Kingdom (GB)
Hammond, Matt (Foresight Group 202205 Partner) Partner (venture partner) Foresight Group (Group) United Kingdom (GB)
Hannah, David (Link Technologies 201409 Head of Marketing) Sales Manager / Marketing Manager Link Technologies Ltd. United Kingdom (GB)
Hardy, David (ACD/Labs 201404 MS Product Manager before Waters UK + Shimadzu UK) Product Manager (personnel) Advanced Chemistry Development (ACD/Labs) (Group) United Kingdom (GB)
Harold, Theodora (Crescendo Biologics 201905– CEO before CFO before PsiOxus + Mission Tx + OrthoMimectics + Cytomax) Chief Executive Officer (CEO) Crescendo Biologics Ltd. United Kingdom (GB)
Harrison, Tim (Almac 201506 VP Drug Discovery at Almac Discovery) Research & Development Manager Almac (Group) United Kingdom (GB)
Harvey, Lucy (QuantuMDx 201506 Business Development + Marketing Officer) Business Development Manager / Strategy Manager QuantuMDx (Group) United Kingdom (GB)
Hasan, Rafiq (Complement Therapeutics 202202– CEO before Exact Therapeutics + Bayer + Novartis) Chief Executive Officer (CEO) Complement Therapeutics (CTx) (Group) United Kingdom (GB)
Hassabis, Demis (Alphabet 202107 CEO + Co-Founder of DeepMind) Chief Executive Officer (CEO) Alphabet (formerly Google) (Group) United Kingdom (GB)
Haurum, John (F-Star 201205–201810 CEO before ImClone System + Symphogen LEFT 10/18) Chief Executive Officer (CEO) Sino Biopharm (Group) United Kingdom (GB)
Hawkins, Tim (Schauenburg 201308– Finance Director at Markes Intl before PriceWaterhouseCoopers) Chief Financial Officer (CFO) Schauenburg (Group) United Kingdom (GB)
Healey, Joseph R.J. (Joe) (NanoSyrinx 202012 CEO + Co-Founder) Chief Executive Officer (CEO) NanoSyrinx Ltd. United Kingdom (GB)
Heggie, Theresa (Freeline Therapeutics 202006– CEO before Alnylam + Shire + Jerini + Baxter + Janssen) Chief Executive Officer (CEO) Freeline Therapeutics (Group) United Kingdom (GB)
Hepburne-Scott, Charlotte (Optimum Strategic Communications 202104) Public Relations Manager / Investor Relations Manager Optimum Strategic Communications United Kingdom (GB)
Herrmann, Max (Silence Therapeutics 201108 CFO + acting CEO beforre Intercytex 200809– CFO) Chief Financial Officer (CFO) Silence Therapeutics (Group) United Kingdom (GB)
Herschel, Candice (LifeScience Connect 202309 Head of Community) n. a. LifeScience Connect Ltd. (LifeScience ORG) United Kingdom (GB)
Herzog, Christian (Holtzbrinck 202306 Chief Product Officer at Digital Science + Co-Founder of Dimensions) Product Manager (personnel) Holtzbrinck (Group) United Kingdom (GB)
Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) Attorney / Lawyer Freshfields (Group) United Kingdom (GB)
Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) Chief Executive Officer (CEO) Freenome (Group) United Kingdom (GB)
Hill, Adrian (Univ Oxford 201506 Professor + Director of Jenner Institute) Professor University of Oxford United Kingdom (GB)
Hirsch, Volker (United Kingdom (govt) 202210– CCO at Medicines Discovery Catapult before Amadeus Capital) Chief Commercial Officer (CCO) United Kingdom (GB) (govt) United Kingdom (GB)
Hirst, Simon (Sygnature Discovery 201112 CEO + Founder) Chief Executive Officer (CEO) Sygnature Discovery (Group) United Kingdom (GB)
Hockley, Christine (United Kingdom (govt) 202402 Managing Director for Funds at British Patient Capital) Managing Director United Kingdom (GB) (govt) United Kingdom (GB)
Hogan, Simon (HydrogenOne 202205 Chairman) Board member (all kinds of boards: supervisory, advisory, management etc.) Foresight Group (Group) United Kingdom (GB)
Hohm, Tim (Optibrium 202002– Director of Commercial Strategy and Business Development before Novo Nordisk) Business Development Manager / Strategy Manager Optibrium (Group) United Kingdom (GB)
Holland, Richard (Eagle Genomics 201201 CBO + Co-founder) Chief Business Officer (CBO) Eagle Genomics Ltd. United Kingdom (GB)
Holloway, Sakura (Start Codon 201907– Partner + Head of Diligence before Merck KGaA + OneVentures Pty Ltd + Benitec) Partner (venture partner) Start Codon Ltd. United Kingdom (GB)
Hoogenboom, Bart (Univ College London 201909 Prof of Biophysics at London Centre for Nanotechnology) Professor University College London (UCL) United Kingdom (GB)
Hopkins, Andrew (Ex Scientia 201604 CEO) Chief Executive Officer (CEO) Exscientia (Group) United Kingdom (GB)
Horgan (Nguyen), Anne (Viet-Anh) (Cambridge Innovation Capital 202304 Partner) Partner (venture partner) Cambridge Innovation Capital (Group) United Kingdom (GB)
Humphrys, Emily (Cambridge Research Biochemicals 202305 Managing Director) Managing Director Biosynth (since 9/22) (Group) United Kingdom (GB)
Ibrahim, Adrian (Wellcome Trust 202101 Head of Technology Transfer + Business Development at Sanger Institute) IP Manager Wellcome Trust, The United Kingdom (GB)
Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) Chief Executive Officer (CEO) Autolus Therapeutics plc (Nasdaq: AUTL) United Kingdom (GB)
Jackson, Oliver (Peel Hunt 201707) n. a. Peel Hunt LLP United Kingdom (GB)
Jallal, Bahija (Immunocore 201901– CEO before AstraZeneca President MedImmune joined MedImmune 2006) Chief Executive Officer (CEO) Immunocore (Group) United Kingdom (GB)
James, Alison (Coulter Partners 201712 Director PR + Marketing) Public Relations Manager / Investor Relations Manager Coulter Partners (The Coulter Partnership Ltd.) United Kingdom (GB)
Jeffreys, Hayden (Lumora 2013– Commercial Director) Chief Commercial Officer (CCO) Erba Diagnostics Mannheim (Group) United Kingdom (GB)
Jenkins, Richard (Silence Therapeutics 201806– Head of Clinical Development before Takeda + GSK + Roche) Chief Medical Officer (CMO) Silence Therapeutics (Group) United Kingdom (GB)
John, Llewellyn (Nova Capital 200601 Accociated Partners before Deloitte) n. a. Nova Capital (Group) United Kingdom (GB)
Johnson, Kevin Stuart (Medicxi Ventures 201602– General Partner before Index Ventures + PanGenetics + CAT) General Partner (venture partner) Medicxi Ventures (formerly Index Ventures Life Sciences) United Kingdom (GB)
Jung, Christian Billy (Dementia Discovery Fund 202106 Partner formerly HTGF 201305 Investment Manager) Board member, executive SV Health Investors (Group) United Kingdom (GB)
Kang, Rajin (BenevolentAI 202309 VP Communications) Public Relations Manager / Investor Relations Manager BenevolentAI (Group) United Kingdom (GB)
Karlsson, Jan-Anders (Verona Pharma 201403 CEO) Chief Executive Officer (CEO) Verona Pharma (Group) United Kingdom (GB)
Kawaletz, Gregor (Albumedix 202006– CCO before IDT Biologika + Next Pharma + Catalent Pharma Solutions) Chief Commercial Officer (CCO) Sartorius (Group) United Kingdom (GB)
Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta) Board member, non-executive NuCana plc (Nasdaq: NCNA) United Kingdom (GB)
Keen, Nicholas (Bicycle Therapeutics 201701– CSO before Novartis + AstraZeneca) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Bicycle Therapeutics (Group) United Kingdom (GB)
Kerouedan, Christelle (Coulter Partners 202109– Marketing Director before Instinctif Partners) Sales Manager / Marketing Manager Coulter Partners (The Coulter Partnership Ltd.) United Kingdom (GB)
Kerr, Mary (Nerre Therapeutics 201510– CEO before GSK + Advent Life Sciences) Chief Executive Officer (CEO) Nerre Therapeutics Ltd. United Kingdom (GB)
Kerr, Paul (Fusion Antibodies 201205 Managing Director) Managing Director Fusion Antibodies (Group) United Kingdom (GB)
Kirby, Julian (Bico 202207 Business Development Manager at Scienion UK) Business Development Manager / Strategy Manager Bico (Group) United Kingdom (GB)
Koehn, Jadranka (Rentschler 202011 Senior Direct Innovation Partnerships) Business Development Manager / Strategy Manager Rentschler (Group) United Kingdom (GB)
Kramer, Ann (Oxitec 200610 Head Business Development) Business Development Manager / Strategy Manager Third Security (Randal J. Kirk) (Group) United Kingdom (GB)
Krickl, Reinhard (Phagenesis 201609 CEO) Chief Executive Officer (CEO) Nestlé (Group) United Kingdom (GB)
Kruize, Niels (LGC 201108 Sales Director LGC Genomics) Sales Manager / Marketing Manager LGC (Group) United Kingdom (GB)
Kusser, Wolfgang (Automation Partnership 201102– Sales Manager DE+AT+CH before Invitrogen Germany) Sales Manager / Marketing Manager Sartorius (Group) United Kingdom (GB)
Kuzmin, Dmitry (Dima) (4BIO Ventures 2019 Managing Partner) Managing Partner (investment firm) 4BIO Ventures (4BIO Capital) (Group) United Kingdom (GB)
Lancaster, Madeline (MRC LMB 201908 Principal Researcher + Co-Founder of a:head bio) Researcher (university / research institute) United Kingdom (GB) (govt) United Kingdom (GB)
Lanckriet, Heikki (Expedeon 201111 CEO + Founder) Chief Executive Officer (CEO) 2invest (Group) United Kingdom (GB)
Lavino, Francesco Maria (F2G 202104– CEO before Nabriva Therapeutics + Merck (US) + Cubist Pharmaceuticals) Chief Executive Officer (CEO) F2G (Group) United Kingdom (GB)
Law, Richard (Exscientia 202101– EVP Strategic Alliances before Evotec + UCSD + LLNL) Business Development Manager / Strategy Manager Exscientia (Group) United Kingdom (GB)
Lawson, Jennifer (Sartorius 201901 Product Manager for Testing at Sartorius Stedim BioOutsource) Product Manager (personnel) Sartorius (Group) United Kingdom (GB)
Lawton, Vincent (Merck (US) former Managing Director of Merck Sharp & Dohme UK + VP MSD Europe) Managing Director Merck (US) (MSD) (Group) United Kingdom (GB)
Lernbecher, Thomas (4titude Ltd 201710 Co-Founder) Company Founder Azenta (Group) United Kingdom (GB)
Leslie, Carol (Andrew Lloyd & Associates 201509) public relations / investor relations Andrew Lloyd & Associates (ALA) United Kingdom (GB)
Leyendecker, Ludwig (Freshfields Bruckhaus Deringer 201610) Attorney / Lawyer Freshfields (Group) United Kingdom (GB)
Ligner, Emmanuel (General Electric 201812 President + CEO GE Healthcare Life Sciences) Chief Executive Officer (CEO) General Electric (Group) United Kingdom (GB)
next pagenext page 1 2 3 ... 73 74 75 ... 88 89 90  next pagenext page



Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x300px

» top